
TSE:SLF
This summary was created by AI, based on 12 opinions in the last 12 months.
Sun Life Financial Inc. (SLF) has received mixed reviews from various experts. While some indicate that the company is trading at a relatively attractive price compared to Canadian banks, others highlight challenges in the dental segment and asset management performance. Despite recent restructuring efforts, concerns about growth persist, particularly with the company's 5% growth forecast and a PE ratio of 11.7x for 2027, which is seen as inadequate given the broader market conditions. However, many experts believe in the long-term value of SLF, citing its strong dividend growth potential and substantial operations in Asia and the US. Nevertheless, the sentiment surrounding the stock suggests a cautious approach, with calls for watchful waiting amid macroeconomic concerns.
One of the issues with the insurance companies is that they are trading at very low multiples and pay great dividend, which they can continue to do but interest rates really affect these companies. He believes that interest rates will stay low. If you have a 3-5 year time horizon, it would make sense to own this.
Over the last couple of years the lifecos, particularly this one and Manulife (MFC-T) have done more to de-risk their balance sheets and change their product mix. Feels these companies are in relatively good shape, provided we are in a recovery. If we head back into a deep recession, there could be some downside. (See Top Picks.)
When they reduce their exposure to the risks, interest rates and the risk in stock prices, then the life companies can do very well. Today’s action by them was a major move to reduce risks in the US, by selling the annuity business. This will cost them $.22 next year in earnings and takes about $1 billion off of BV. Some people were disappointed but he took the opposite view.
Has been hitting 52-week highs lately. Low interest rates have been a problem for lifecos. Had thought 6 months ago that interest rate were likely to pop up but he is now forecasting that slow growth will be staying with us along with low interest rates. Well-run company. Feels the dividend is safe.
Sold his holdings about 2-3 weeks ago because it was getting quite overbought. Lifecos really depend on what interest rates are doing and what equity markets are doing. With equity markets in the US starting to perform, a lot of the insurers start to do well. Interest rates will remain low, but at least on the side of the equity have been doing well. If you own, you might consider taking some profits. Yield of 5.9% is pretty safe.
Chart is definitely scary and looking like it is getting ahead of itself but had a big beat last quarter on lower capital review charges. Core results have been great for a long time. Just sold their US annuity business, which de-risks the balance sheet. Deployed some assets in Malaysia, which is a very high growth market for them, a signal to investors that they are ready to grow by acquisition again. Trading at around 1.3X Book, pricier than Manulife (MLF-T) so there is probably better value in Manulife but people are going into this one because of the higher dividend. (See Top Picks.)